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Abstract
The application of nanomaterials made of rare earth elements within biomedical sciences continues to
make significant progress. The rare earth elements, also called the lanthanides, play an essential role in
modern life through materials and electronics. As we learn more about their utility, function, and
underlying physics, we can contemplate extending their applications to biomedicine. This particularly
applies to diagnosis and radiation therapy due to their relatively unique features, such as an ultra-wide
Stokes shift in the luminescence, variable magnetism and potentially tunable properties, due to the library
of lanthanides available and their multivalent oxidation state chemistry. The ability to prepare
nanomaterials of relatively smaller sizes has increased the likelihood of use in vivo. In this review, we
summarize the different emerging applications of nanoparticles with rare earth elements as the host or
doped elements for biomedical applications in the past three to four years, especially in the area of
imaging and disease diagnosis. Researchers have made progress in utilizing surfactants and polymers to
modify the surface of lanthanide nanoparticles to enhance biocompatibility. At the same time, specific
antibodies and proteins can also be conjugated to these nanoparticles to increase targeting efficiency for
specific tumor models. Finally, in the near-infrared II imaging window, lanthanide nanoparticles have been
shown to exhibit extraordinary bright emission, which is an exciting development for image-guided
surgery.
Key words: Lanthanide Nanomaterials, Imaging, Sensing, Therapy

Introduction
This is a short review of the current use of
lanthanide nanomaterials for biomedical applications.
The word lanthanide is used colloquially over
lanthanoid, which is the official IUPAC name.
Collectively with Scandium and Yttrium, the term
rare earth element (REE) is frequently used in
geology, science and medicine; however, their relative
natural abundance is not that scarce in most cases.
The f-orbitals start with element 57, lanthanum, the
first of the lanthanides and namesake of the
elementary group. There are so many of these f-block
elements (15, from Lanthanum to Lutetium) it is
necessary for formatting/aesthetic reasons to place

them at the bottom of the periodic table, with the
actinides. Their discovery spans the 19th century,
while the emergence of their widespread utility spans
the latter half of the 20th century until the present day.
As we have learned to harness the unique physics and
chemistry characterized by their f-orbital behavior,
there have been several key applications that have
revolutionized industries, including the development
of phosphors for fluorescent/LED lighting [1] and the
development of rare earth magnets, which now
dominate the design of personal headphones, motors
for electric/hybrid vehicles, wind turbines, and
portable MRI scanners [2-4]. Since 1959, when the
https://www.ntno.org
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Dutch-American physicist and Nobel laureate
Nicolaas
Bloembergen
observed
nonlinear
up-conversion of lanthanides in the Near IR region,
optical properties (photonics) research chiefly focused
on semiconductors and electronic equipment [5].
However, in more recent times, and primarily
through adaptation enabled by nanotechnology,
significant achievements have been made in basic
research of rare earth element chemistry for
biomedical applications [6].
In general, molecular-level based imaging is
increasingly used for disease diagnosis and guidance
of surgery [7-14]. Among the most widely used in vivo
applications are planar and tomographic fluorescence
and bioluminescence imaging. However, despite their
utility, these techniques are primarily restricted to
pre-clinical use. Factors that have prevented
translation from the bench to the bedside include
depth-penetration considerations, regulatory issues,
and toxicity of the lanthanides [15, 16]. A recent
development in lanthanide element based near IR-II
nanoprobes [17]
successfully overcame
the
shortcomings of traditional fluorescence contrast
agents by extending the imaging window closer to the
near IR-II region (1000-2000 nm). In parallel,
nanotechnology researchers dedicated to developing
rare earth nanoprobes with improved surface
modification, morphology, and size, have enabled
increased function for diagnosis or targeting.
In terms of treatment, especially tumor
treatment, due to the powerful optical properties of
lanthanides, there are remarkable effects when
combining them with agents designed for
photothermal therapy (PTT) or photodynamic
therapy (PDT). Hereafter, we discuss the
development
of
lanthanide
element-based
nanomaterials in biomedicine, especially for tumor
imaging and therapy. Due to several existing excellent
reviews on the topic [18-23], we present here exciting
recent developments in the past few years. Starting
with lanthanide nanoparticle synthesis and surface
modification strategies, we summarize what
approaches have made them suitable for in vivo
studies. Next, we evaluate how researchers have
utilized the rare earths' unique properties to achieve
specific goals in cancer diagnosis, Immunotherapy,
chemotherapy, and imaging guide surgery. Lastly, we
review applications other than cancer such as, bone
imaging, blood vasculature imaging and COVID-19
detection.

Surface modification of lanthanide-based
nanoparticles for in vivo studies
For pre-clinical nanomedical research, especially
in inorganic metal/metal oxide nanoparticles, the
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highest priority is to enhance biocompatibility. Most
biomaterials are considered as foreign matter to the
host, especially the inorganic materials, and will
induce the rejection reaction. The successful design of
an in vivo used material must include low toxicity,
longer circulation time, and even biodegradable or
smaller enough size for extraction from the
glomerulus. Making the lanthanide nanomaterial
more biocompatible through surface modification
became a popular research field for material scientists:
Liu et al. developed a novel inorganic oxide
nanoprobe based on amine-functionalized tetragonal
nanoparticles
(<
5nm)
ultrasmall
ZrO2Ln3+
synthesized through a simple solvothermal technique
(Fig. 1C). To substitute the natural hydrophobic
ligands on the surface of NPs, amine and phosphate
groups were introduced for a ligand exchange
reaction. They show the use of this hydrophilic
Ln3+-based long-lived luminescence as a sensitive,
time-resolved fluorescence resonance energy transfer
(FRET) nanoprobe to identify avidin with a detection
limit as low as 3.0 nM [24]. Fischer et al. reported
synthesizing a series of sub-15 nm alkaline-earth
lanthanide fluoride upconversion nanoparticles with
different doping combinations (M1-x Lnx F2+x, MLnF)
(Fig. 1B). Then, CaF2 shells, which have earlier been
demonstrated to be biocompatible, are employed for
passivation to increase the upconversion performance
of these nanoparticles by more than five orders of
magnitude
while
also
enhancing
their
biocompatibility [25]. Zhijie Wang et al. presented a
facile one-pot procedure for producing highly
hydrophilic and biocompatible NaGdF4:Yb3+/Er3+ and
NaGdF4:Yb3+/Tm3+ nanocrystal by thermal hydrolysis
of lanthanide-oleate precursors and sodium fluoride
by added ω-dicarboxylic polyethylene glycol
(HOOC-PEG-COOH) (Fig. 1D).
Moreover, NaGdF4:Yb3+/Er3+ nanocrystals have
been employed effectively as dual-modal imaging
contrast agents for optical and MRI imaging in
vivo[26]. In the recent work by Shane Plunkett et al.,
the procedure was improved by using Janus-type
dendrimers, which have individual carboxylates on
the surface of the ligand for conjugation to
NaYF4-based nanocrystals, doped with Yb3+ (20%)
and Er3+ (20%), neutral polyethylene glycol (PEG)
groups for water solubility. They also encapsulate a
pH-sensitive dye, Eriochrome, as the center of the
dendrimer. These Janus-dendrimers modified NaYF4
based nanocrystals were excellent vascular markers,
enabling for depth-resolved mapping of specific
capillaries in the mice brain achieved a depth of 1000
um under continuous wave (CW) stimulation with a
relatively low energies level of no more than 20 mW
(Fig. 1A) [27]. Another exciting aspect of lanthanide
https://www.ntno.org
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nano oxides is unusual water-solubility, which even
could be used to functionalize other materials to
render them hydrophilic. In Wen Luo et al.’s recent
work, they doped the Titanium−Oxo Cluster with
Eu(III) , Tb(III), and Yb(III) to form water-soluble
lanthanide− titanium− oxo clusters (LnTOCs) which
could quickly disperse in aqueous media to form a
stable solution with aggregation of the clusters. The
photocatalytic behavior, fluorescence sensing, and
fluorescent labeling have all been retained and
verified through in vitro cell imaging (Fig. 1E) [28].

Cancer imaging and therapy
Ren et al. developed Er-based lanthanide
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nanoparticles NaErF4:2.5 %Ce@NaYbF4, coupled with
Dye-brush polymer (Dye-BP) to promote the
4I1
4
transition,
achieved
675-fold
3/2→ I15/2
enhancement at 1525 nm wavelength near the IR II
imaging window. They further conjugated a
tumor-targeting angiopep-2 peptide, which could
target the glioma in a mice model. Under the guidance
of this near IR luminescence probe, they successfully
removed the glioma from the mouse brain (Fig. 2A)
[29]. Peroxynitrite(ONOO−) is over-expressed in the
tumor-microenvironment. Zhao et al. developed a
lanthanide-based β-NaYF4@NaYF4:1%Nd NIR-II
nanosensor which attached an ONOO− responsive
dye MY-1057. They utilize the specific energy transfer

Figure 1: A) Janus-type dendritic ligands: Structures and a cartoon of the synthetic sequence illustrating assembly of compound 11 as an example. B) Schematics and
corresponding transmission electron microscope (TEM) images(i-iv) C) The covalent coupling of biotin with NPs can be achieved in DMF solution by use of HBTU and DIEA as
coupling reagents. D) (i) Upconversion spectra of NaGdF4:Yb3+/Er3+ nanoparticles and NaGdF4:Yb3+/Tm3+ nanoparticles excited with a 980 nm laser. (ii) The digital photographs
of colloidal solution of NaGdF4:Yb3+/Er3+(20/2 mol) and NaGdF4:Yb3+/Tm3+(20/0.5 mol) nanoparticles in water under natural light, in dark and excited with a 980 nm laser,
respectively. (iii) The energy levels diagrams and corresponding transfer mechanism of Yb3+ to Er3+ and Yb3+ to Tm3+. E) Water-Soluble Lanthanide−Titanium−Oxo Cluster
[10-14].

https://www.ntno.org
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between the ONOO- to the MY1057 dye and finally
excite the β-NaYF4@NaYF4:1%Nd nanosensor in the
NIR-II region. With the NIR light from the
nanosensor,
tumor
lesions
(Hepatocellular
Carcinoma) could be distinguished from normal
tissue (Fig. 2C) [30]. PDT and CDT (chemodynamic
therapy) is usually limited by glutathione and
hypoxia in the tumor. Jiating Xu et al. developed a
copper/manganese silicate nanosphere (CMSN)covered by Yb3+/Er3+/Tm3+shell nanoparticles which
not only provide upconversion (UC) and
downconversion (DC) emissions for NIR (1000 nm –
1700 nm wavelength, the significance of which is
explained later in this section) imaging but also
contribute to enhancing the potential for PDT through
promoting the O2 to singlet 1O2 by the NIR light
emitting from the lanthanide element (Fig. 2E) [31].
Since some of the lanthanides are also
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paramagnetic, they can be used as MRI contrast
agents. Zhang et al. synthesized Lanthanide−Cyclen−
Camptothecin nanocomposites encapsulating Gd(III)
and Yb(III) complexes and the anticancer drug
camptothecin into a micelle, offering real-time NIR /
MR dual model imaging and chemotherapy (Fig. 2B,
D) [32]. Lanthanide nanoparticles could be used as a
platform incorporated with other nanomedicines for
theranostic approaches. Xu et al. integrated CuS
nanoparticles (PTT agents) and g-C3N4 QDs (PDT
agents) on silica-coated NaGdF4:Yb,Tm@NaGdF4:
Nd,Yb UCNPs. When they applied an 808 nm laser to
this nanocomplex, the lanthanide UCNP would shift
the light to UV/vis region and simultaneously active
the PPT and PDT agent to achieve the effect of
combination therapy [33]. Similarly, another group of
researchers utilized the same material and 808 nm
laser for image-guided tumor resection surgery by

Figure 2: A) Schematic illustration of T2-weighted magnetic resonance imaging (MRI), and noninvasive NIR IIb fluorescence imaging of a deep-seated and small-sized
orthotopic glioma under the assistance of focused ultrasound (FUS) B, D) (i) In vivo T1-weighted MR images of the mice bearing HeLa xenograft from 0 to 24 h after the injection
of Gd/YbNPs and Gd DOTA (control). (ii) Plots of 1/T1 vs. [Gd] to determine r1 of Gd-DOTA and Gd/YbNPs hybrid nanoparticles. C) Noninvasive intensity-based imaging,
lifetime-based imaging of a mouse bearing multiple HCC lesions and optical photo of the dissected liver. E) Theranostic mechanism of PEG/ LDNPs@CMSNs for TME and NIR
laser co-enabled PDT/CDT and trimodal bioimaging F) Lanthanide−Cyclen−Camptothecin Nanocomposites for Cancer Theranostics Guided by Near-Infrared and Magnetic
Resonance Imaging [15-19].
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doping Ce3+. They achieved an 11-fold enhancement
of the NIR-II emission above 1500nm and successfully
removed tumors in a colorectal cancer mice model
[34]. Doping lanthanide elements into polymer
nanoparticles is another strategy for cancer imaging
or therapy since most organic/polymer nanoparticles
can degrade over specific pH environments. Miao
Feng et al. introduced hydrophobic NaGdF4:
2%Nd@NaLuF4 nanocrystals ultrasmall nanoparticle
and doxorubicin into a 300 nm pH-sensitive
degradable mPEG-PLGA nanomicelles for imaging
and chemotherapy application (Fig. 3A) [35]. While
these approaches all used nontargeted agents,
lanthanide nanoparticles were also targeted to a
specific cancer model for imaging when coupled with
targeted peptides. Jingxue Cao et al. designed a
αvβ3/αvβ5 and aminopeptidase-N-receptor targeting

peptides conjugated to NaYF4:Yb nanoparticle as
NIR-II nanoprobes for in vivo imaging of lung cancer
(Fig. 3C) [36]. To maximally lower the toxicity of the
inorganic lanthanide nanoparticle in vivo, an
excretable lanthanide nanoprobe for imaging and
surgical guidance in the NIR-II window has been
developed by Daifen Li and his colleagues (Fig. 3B).
They encapsulate ultra-small hydrophobic NaYF4:Nd
7% into bio-degradable liposomes. This strategy can
quickly clear their particle via the kidneys after
intravenous injection with a half-life of 23.0 h for the
liver and 14.9 h for the spleen [37]. Metal−organic
frameworks (MOFs) are posited as excellent
photosensitizers for photodynamic therapy (PDT) in
cancer therapy. However, the efficacy of the MOFs
PDT has been limited by the tissue penetration of the
visible excitation light (Fig. 3F).
When
coupled
with
upconversion
lanthanide
nanoparticles, a more penetrating NIR
light source outside the body can be
used. The NIR light can be transferred
to visible light via upconversion
lanthanide nanoparticles inside the
body, which could further excite the
MOFs to generate singlet oxygen and
significantly increase PDT efficacy
[38].
As
an
alternative
to
upconversion, one can also manipulate
lanthanide
nanoparticles
for
a
down-converting
application.
Downconversion means shifting the
UV/visible (200-400nm) or near IR
(800-1000nm) to longer red light
(600-700nm) or far IR region (beyond
1500 nm), respectively. Hongjie Dai’s
group at Stanford designed a
biocompatible cubic-phase (α-phase)
erbium-based lanthanide nanoparticle
attached with anti-PD-L1 antibodies
that exhibits bright downconversion
emission at ~1,600 nm for dynamic
imaging of cancer immunotherapy in
mice
(Fig. 3D) [39]. Another group
Figure 3: A) Schematic illustration of the bioapplication of DMDNs(DOX@mPEG-PLGA@DCNP
successfully converted a 980 nm laser
nanoparticles). B) Schematic illustration of excretable lanthanide nanoparticles for multifunctional biomedical
imaging and surgical navigation in the second near-infrared window. C) Treated group: tumor-bearing mice
emission to 1500 nm (NIR-II region)
injected with UCNP@P- RGD-NGR. Digital photos were taken at 0, 15, 30, 60, 120 min after injection under
980 nm excitation.D) i), Schematic illustration of the hydrophilic ErNPs with cross-linking polymeric layers and
via poly(acrylic acid) (PAA)-modified
amine groups on the surface as conjugation sites. ii), DLS spectra of hydrophilic ErNPs with polymeric
NaLnF
4:40Gd/20Yb/2Er nanorods for
cross-linked network and NIR-IIb cerebral vascular image (left) by intravenous injection of 200 μl ErNPs (40 mg
ml−1) and excitation by a 970 nm LED (30 fps). The luminescence intensity of an inferior cerebral vein was
cancer metastasis and vessel imaging
plotted as a function of time (iii), showing the cardiac cycles (iv) with a heartbeat frequency of 3.67 Hz by fast
(Fig. 3E) [40]. Downconverting
Fourier transformation (FFT, lower right). Scale bar, 5 mm E) i) Digital photograph of tumor-bearing mouse
and in vivo NIR-IIb fluorescent imaging (the green circle indicated the tumor site). ii, iii) Digital photographs of
technology could even be applied to
the isolated organs/ tumor and the corresponding ex vivo NIR-IIb imaging, respectively. F) i) Schematic
nuclear imaging, especially Cerenkov
illustration of the synthesis of UCDs and UCSs through the conditional surface engineering of UCNPs. The
structure of porphyrinic MOFs is illustrated in the right column. ii)TEM images from left to right is UCNPs,
imaging.
A
europium
oxide
UCDs, and UCSs. Scale bar, 50 nm. iii) Elemental mapping images of a single (left to right) UCD and (f) UCS.
nanoparticle was utilized to shift blue
Scale bar, 50 nm. G) (i-iv) Morphology of NdIII-IP virus-like nanodrugs and IP nanospheres observed by SEM,
TEM [21-29].
Cerenkov radiation to the more
https://www.ntno.org
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penetrative red-light region, which significantly
enhanced the Cerenkov light for lymph node and
tumor imaging [41, 42].
Researchers have also designed rare-earth
nanoparticles with different morphologies, resulting
in unexpected and interesting effects under certain
circumstances. Yang Li et al. created a virus-like
nanoconjugate that included a NIR-II fluorescence
agent (IR825), a chemotherapy drug (pemetrexed,
PEM), and a lanthanide element (Nd(III))(Fig. 3G).
The spike-like poly(ethylene glycol) shell protected
the nanoparticle from immune clearance and
enhanced the in vivo circulation time [43]. Xu et al.
produced two-dimensional ultrathin lanthanide
oxyiodide nanosheets for anticancer drug delivery.
Those nanosheets exhibit remarkable drug loading
capacity (300 wt.%) compared to other nanomaterial
morphologies [44]. The unique paramagnetic
property of gadolinium makes it an excellent MRI
contrast agent among rare earth elements.
Traditionally, Gd is usually chelated to small
molecules. However, material scientists could also
make a nanoparticle that uses Gd as the main or
doped
component.
With
the
benefit
of
nanotechnology, the Gd nanoparticle could reach the
targeted area, relying on the EPR effect, or the particle
could be encapsulated with other functional elements
to achieve different imaging modalities. Ye Kuang
and colleagues doped Gd into HfO2 to create a
Gd2Hf2O7 nanoparticle that utilizes the Gd as an MRI
contrast agent and Hf as a radiosensitizer. They
surface modified the nanoparticle with RGD peptides
and loaded the particle with cisplatin to a create a
potential
MRI-guided
combined
chemo-/
photothermal-/radiotherapy
nanoplatform
for
drug-resistant tumors [45]. McLeod et al. incorporated
a Gd(III) complex into a Zr-based MOF
(Metal-organic framework) through solvent-assisted
ligand incorporation (SALI) and tested the combined
MOFs as a potential MRI contrast agent [46]. By
combining Gd and barium titanate, researchers Peng
Wang et al. created a dual MRI and X-ray imaging
agent [47]. Meanwhile, Yao Cai et al. labeled human
heavy chain ferritin with Gd for enhanced MRI tumor
imaging applications [48]. The most abundant
lanthanide element, Cerium, is another potential
candidate for biomedical applications such as sensors
or imaging platforms. With the surface oxygen
vacancies, CeO2 has been utilized as a contract agent
or carrier for another rare earth element for imaging
purposes. CeO2 also presents native fluorescence due
to the presence of Ce3+ [49]. Meanwhile, CeO2 can also
be used as a convenient host lattice with which to
combine with another lanthanide element to achieve
more imaging modalities. Anne et al. doped
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ytterbium and gadolinium into the CeO2 nano cubes
for MRI and Near IR imaging on cancer cells [50].
Chulun Shao et al. utilize the abundant oxygen
vacancies on the CeO2 surface and integrate the Gd
for
DCE-PWI
(dynamic
contrast-enhanced
perfusion-weighted imaging) MRI [51]. Since
lanthanide elements are in the d-block of the periodic
table, they are also considered as high atomic number
elements, which usually provide a good contrast for
X-ray imaging. Zuwu Wei et al. developed a hollow
CeO2-ZrO2 hybrid nanoplatform labeled with Gd for
MRI/CT imaging and drug (Dox) delivery for
heterotopic, subcutaneous human liver cancers [52].

Radiotherapy of 177 Lutetium
Lutetium is a unique member of the lanthanide
family since one of its isotopes, Lutetium 177,
intrinsically has electron and high energy gamma
emission, making it a good candidate for targeted
radiotherapy. 177 Lu has been used as a radiotherapy
agent for a long time in the literature [53], and more
recently has been chelated to small molecule peptides
or prostate-specific membrane antigen (PSMA)
inhibitors for targeted radiotherapy of neuroendocrine tumors and prostate cancers. Here, we
touch on a subsection of the unique applications of
177Lu combined nanotechnology in recent years.
Rodrigo et al. recently synthesized an Eu-doped
Mesoporous SiO2 labeled with 177 Lu for HT-29
colorectal cancer imaging and radiotherapy. The
author cleverly uses the beta emission from the 177Lu
for a therapy study, and the gamma emission for
SPECT imaging [54]. Another group at the University
of Wisconsin (Yu et al.) developed a facile approach to
177Lu-Porphyrin-PEG-Nanocomplexes
assembling
which
combined
fluorescence
imaging,
photodynamic therapy with positron emission
tomography imaging, internal radiotherapy and
specifically targeted the tumor cell mitochondria [55].
Metal nanoparticles could also be labeled with 177Lu
for therapy study. Pei Pei et al. chelated gold
nanoclusters with 177Lu and 99mTc, and could
strengthen the radioisotope therapy efficiency and
induce anticancer immunity by activating dendritic
cells [56].

Biosensing and other biomedical
applications of lanthanide nanomaterials
Based upon excellent optical features, such as
low background fluorescence, and high sensitivity,
lanthanide nanomaterials can be applied to various
biosensing areas, such as pH detection, essential
physiological ions, ROS detection, temperature
monitoring or even COVID-19 testing. A current,
pandemic related application of lanthanide
https://www.ntno.org
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nanoparticles is the utilization of self-assembled LNPs
(lanthanide-doped polystyrene nanoparticles) as a
fluorescent sensor to detect anti-SARS-CoV‑2 IgG
(Fig. 4C) [57]. Inflammation imaging has become, next
to cancer imaging, an essential diagnostic tool for
disease detection. Zhao et al. developed an ultra-small
glutathione
(GSH)-modified
lanthanide
downconversion nanoparticle system that could
precisely target and detect ROS in the inflammation
through a cross-linking strategy (Fig. 5C). Light and
heat have always been a pair of inseparable factors.
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The intracellular thermal energy could affect the
energy transfer of the outer shell electron of the
lanthanide element. The outer shell electron
configuration usually determines the light emission
intensity of the rare earth element. Piñol et al.
employed this theory to develop innovative Ln3+
doped polymeric micelles, which could achieve
real-time 2D mapping of the intracellular temperature
of breast metastatic adenocarcinoma cells (Fig. 5B)
[59].

Figure 4: A) In vivo NIR-II imaging of C57BL/6 mice (n = 3) bone in the NIR-IIa 1345 nm and NIR-II 1064 nm windows. In vivo fluorescence of the whole body in (a) prone, (b)
supine, and (c) lateral. B) Schematic diagram of a nude mouse by intragastric administration and intravenous injection with cssEr-PEG and cssNd-PEG aqueous dispersions,
respectively. C) Design and fabrication of the developed assay. (i) Lateral flow test strip. (ii) Assay. D) Projections of a z-stack of images of a HeLa cell incubated with ECP-NPs
(PMMA-COOH 10% at 40% [Eu(tta)3phen]). ECP-NPs are shown in magenta and the cell membranes in turquoise (costained with DiD). E) Photograph of papery patterns under
1540 nm excitation (power density: 10 W/cm2). (i) In vivo multiplexing upconversion imaging with aqueous CS-CS4 nanoparticles under 1540 nm excitation. Bright-field (left) and
dark-field (right) (power density: 0.5 W/cm2), ii. F) Luminescence cell imaging of Ln-nMOFs. (above) Confocal images of the CT26 cells incubated with Eu-BDC-PEG and
Tb-BDC-PEG nMOFs for 3h. green and red fluorescence represent the emission from Tb3+ and Eu3+ the PEGylated nMOFs, respectively. Scale bars correspond to 50 μm. (below)
In vitro RLI of CT26 cell pellets under X-ray excitation of (i) blank cells and cells incubated with (ii) EuBDC-PEG, (iii)TbBDC-PEG, and (iv) EuxTbxBDC-PEG nMOFs for 24 h
[30-36].
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Similarly, the Mott-Seitz model could describe
the light and temperature relationship as equation (1),
Mott-Seitz Model τ(T) =

τ0

1+𝐶|𝑒𝑥𝑝(−∆𝐸/𝑘𝑇𝑏 )

(1)

where T is the thermodynamic temperature in K, T0 is
radiative lifetime, E the activation energy of the
thermal-quenching effect, and kb is the Boltzmann
constant. By applying this theory, Yuen Pan et al.
created Eu2+/Eu3+ co-doped Sc2O3 nanoparticles,
which precisely monitor the temperature changing
through the light emission intensity. The unique part
of this study was using Eu2+ as the primary lattice host
rather than Eu3+. Due to the lack of complete 5s and 5p
orbitals protection, the Eu2+ 4f7 electron configuration
exhibits more sensitivity to the exterior environment,
such as temperature [60]. Jianan Liu et al. integrate the
upconversion nanoparticle with a commercial K+
indication into a hollow mesopores silica nanoparticle
to create a potassium ion sensor for in vivo potassium
imaging. By irradiating the NIR light to the
upconversion nanoparticle, the NIR light can be
transferred to UV light, further activating the K
indicator to detect the intracellular K+ level [61].
Chantal Galaup et al. evaluated a possibility of
luminescent lanthanide material that could detect
ROS in the context of Alzheimer’s disease [62]. Cyrille
Charpentier et al. designed a particular ligand that
could boost the brightness of the terbium
nanoparticles and link the nanoparticle to different
biological molecules to form specific biosensors to
detect biotinylated dyes or even epidermal growth
factor receptors (EGFR) [63]. For more biomedical
applications, Shuqing He et al. found a unique
property of DSPE-mPEG encapsulated rare-earthdoped nanoparticles, which surprisingly exhibited a
high affinity to the bone. They used this particle for
dedicated imaging of the bone and lymph nodes (Fig.
4A). The mechanism of this bone affinity is mainly
caused by the hydroxyapatite mineral binding ability
and white blood cell uptake [64]. Rather than laser
excitation, lanthanide nanoparticles could also be
excited by ionization radiation, like Cerenkov
radiation, X-rays etc. [41, 42]. Neufeld et al., using
X-ray as a radiation source, successfully excited
nanoscale Ln-MOFs (Ln = Eu or Tb) that emit at
400-700 for radioluminescent cell imaging (Fig. 4F)
[65]. Another benefit of lanthanide nanoparticles is
the long luminescent half-life, eliminating the
influence of autofluorescence from body tissue.
Andreas Reisch’s group developed poly(methyl
methacrylate)-based particles doped with a high
percentage of europium complexes. By utilizing these
rare earth nano complexes, they achieved
background-free single-molecule imaging in live cells
(Fig. 4D) [66]. By adjusting the doping percentage of

different lanthanide element components, the
emission of the lanthanide nanoparticle could easily
be turned into the desired range. With this feature, the
same wavelength excitation source could be used to
achieve different emission wavelengths for
multichannel or multiplexed imaging (Fig. 4B, E) [67,
68].
In an innovative and unusual exploration,
Zhiming Deng et al. fed silkworms with
NaYF4:Gd3+/Yb3+/Er3+@SiO2 nanocrystals to produce
a NIR-II fluorescent silk fibroin-based material (Fig.
5B). They further bioengineered the upconversion silk
by attaching it to an implantable stent for mice to
verify the potential for in vivo applications [69].
Toxicity remains a primary challenge for in vivo
inorganic nanomedicine, and the lanthanide
nanoparticles are no exception [70]. Gadolinium
chelates are frequently used as MRI contrast agents
and recently have been identified as causing renal
impairment through slowly developing nephrogenic
systemic fibrosis (NSF) in humans that had received
certain gadolinium-based MR contrast agents [71].
The FDA also issued a safety warning for
gadolinium-based contrast agents chelated by linear
chelators such as DTPA after observations that Gd
could be retained inside the body, even in the brain,
for months or even years after the MRI scan. Other
studies have shown there is nephrotoxicity of
gadolinium-based contrast agents [72]. Meanwhile,
other lanthanide ions, like Tb3+ Pm3+ or Eu3+ could
bind to the Ca2+ binding sites of the intestinal
membrane, affecting ion channel transportation,
leading to toxicity. Sc3+, Y3+, and La+ have been found
to bind to globulin and DNA, which could cause
damage [73]. Encapsulating lanthanides into rapidly
excretable nanoparticles and/or coating with a
biocompatible polymer which decreases the time of
the lanthanide inside the body, can minimize toxicity.
Dana M. et al. tested their NaGdF4:Tm3+ Yb3+
nanoparticles on a variety of cancer cell lines and
C.elegans. detected no toxicity over a wide
concentration range [74]. For the same kind of
particle, Huaiyong Xing et al. showed after seven
days post-injection to the mice, the NaGdF4:Tm3+
ultra-small nanoparticle could be excreted into feces
and urine [75]. Jin Yan et al. developed a safe
peptide-lanthanide nanocluster for cancer drug
delivery. They functionalized 5 nm lanthanide cores
with two types of targeting peptide, which increased
the tumor-targeting efficacy and decreased the
toxicity of the nano cluster [76]. Based on the issue of
toxicity and the development of strategies to eliminate
concerns with introducing lanthanides into the body,
the design of lanthanide nanomaterials for biomedical
applications continues to focus on developing
https://www.ntno.org
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Figure 5: A) Microscopy images (recorded in the Eu3+ channel) of the MDA-MB-468 cells incubated with DNPD-based polymeric micelles. i)The blue and red points mark,
respectively, the locations used for temperature determination of the darker and brighter regions. ii)Temperature histograms obtained from the selected points indicated in
panels B) i) A schematic illustration of the in vivo NIR-II imaging of the implanted biological stent model made from the hybrid silks. ii) Allergy test of a mouse by directly exposing
the abdomen skin to the hybrid silks for 96 h. iii. In vivo UC/NIR-II imaging of the subcutaneously implanted stent model with a square shape made from the hybrid silk under 980
nm laser excitation. iv)The corresponding fluorescence intensity. v) A digital photograph and in vitro phantom NIR-II imaging of other phantom biological stents with ‘‘H’’, ‘‘N’’,
and ‘‘U’’ shapes. vi and vii. In vivo NIR-II imaging after subcutaneously implanting the models in the mouse abdomen under the excitation of a 980 nm laser C,) i) NIR-II
fluorescence bioimaging of the acute local epidermal inflammation with various nanoprobes. ii) SNR as a function of time in the inflamed area. iii) In vivo I-PEM bioimaging. iv)
I-PEM signal intensity as a function of time in the inflamed area with various nanoprobes. v) ICP-MS results of the retention of various nanoprobes in the inflamed area. vi)
Pharmacokinetics of DCNP@GSH in blood and urine excretion after iv) Injection. ICP-MS results of kidney biodistribution as a function of time. Insert shows NIR-II bioimaging
of the bladder. vii) Excretion of DCNP@GSH and DCNP@OH in urine and feces as a function of time. h) Biodistribution of DCNP@GSH and DCNP@OH nanoprobes in the
liver (Li), spleen (Sp), and kidney (Ki) after two weeks [37-39].

ultra-small and clearable nanoparticle approaches,
while still seeking to take advantage of the available
optical properties to enhance sensitivity for disease
diagnosis and future innovation in treatment of
disease [35, 37, 41].

Conclusion and Prospects
Biomedical imaging is a multidisciplinary
research field involving physics, chemistry, molecular
biology, photonics and materials science. In this
rapidly developing research field, new materials, new
technologies, and new applications arise quickly. Due
to the long time for clinical translation, it is essential
that biomedical researchers become aware of new
materials opportunities that enable improved
sensitivity in diagnostic medicine, and increased
efficacy/reduced toxicity in therapeutics. This review
provided a short summary of the applications of
lanthanide nanomaterials published over the past few
years, including cell imaging, living tumor diagnosis,
lymphatic and vascular imaging, and imaging guide
surgery. Given the extensive literature on this global
research topic, it is difficult to cover all aspects of rare

earth nanomaterial science and biomedical
applications. Lanthanide luminescent nanomaterials
have made outstanding contributions to the field of
biomedicine in the past few decades, mainly due to
the apparent advantages of rare earth luminescent
materials, such as stable photochemical properties,
negligible photobleaching, and high fluorescence to
noise ratio. The excitation light wavelength is in the
ideal biological window (NIR region), which has
better penetration, no damage to the normal tissue
and high sensitivity. Because of the unique properties
of rare earth luminescent materials, they could
provide advantages that other probes cannot achieve
and a valuable technical method to biologists and
physicians. Optical imaging of rare earth materials is
essential for various technologies required for modern
bioanalysis and bioimaging. It has allowed for the
creation of unusual nanosensors based on the unique
properties
of
the
lanthanides.
Overall,
lanthanide-based agents have shown remarkable
application prospects in fluorescence imaging,
medical diagnosis, and treatment.
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